Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism

American Journal of Kidney Diseases

Volumn 28, Issue 5, 1996, Pages 704-712

  Malberti, Fabio ^a   Corradi, Bruno ^b   Cosci, Paolo ^b   Calliada, Fabrizio ^b   Marcelli, Daniele ^b   Imbasciati, Enrico ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b NONE

Author keywords

calcitriol; Hyperparathyroidism; parathyroid function; parathyroid hormone; set point for calcium

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DRUG EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; ORGAN SIZE; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM;

EID: 0029987324     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90252-8     Document Type: Article

References (35)

1. Llach F, Massry SG: On the mechanism of secondary hyperparathyroidism in moderate renal failure. J Clin Endocrinol Metab 61:601-606, 1985
2. Feinfeld DA, Sherwood LM: Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure. Kidney Int 33:1049-1058, 1988
3. Felsenfeld AJ, Llach F: Parathyroid gland function in chronic renal failure. Kidney Int 43:771-789, 1993
4. Kremer R, Bolivar I, Goltzman D, Hendy G: Influence of calcium and 1,25 dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125:935-941, 1989
5. Szabo A, Merke J, Beier E, Mall G, Ritz E: 1,25-Dihydroxyvitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 35:1049-1056, 1989
6. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovzter MN: Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 78:1296-1301, 1986
7. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin R: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136-2143, 1984
8. Delmez JA, Tindira C, Grooms P, Dusso A, Window DW, Slatopolsky E: Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. J Clin Invest 83:1349-1355, 1989
9. Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F: Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int 36:1093-1098, 1989
10. Andress DL, Norris KC, Coburn JW, Slatopolsky E, Sherrard DJ: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279, 1989
11. Malberti F, Surian M, Cosci P: Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Nephrol Dial Transplant 8:822-828, 1992
12. Sprague S, Sharon M: Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol. Am J Kidney Dis 19:532-539, 1992
13. Gallieni M, Brancaccio D, Padovese P, Rolla D, Bedani P, Colantonio G, Bronzieri C, Bagni B, Tarolo G: Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Kidney Int 42:1191-1198, 1992
14. Fischer ER, Harris DCH: Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol 40:216-220, 1993
15. Quarles D, Yohay D, Carroll B: Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45:1710-1721, 1994
16. Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matjumoto T, Ogata E, Kurokawa K: Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68:221-228, 1994
17. Quarles LD, Lobaugh B, Murphy G: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145-150, 1992
18. Hercz G, Pei Y, Grenwood C, Manuel A, Shaiphoo C, Goodman WG, Segre GV, Fentona S, Sherrard DJ: Aplastic osteodystrophy without aluminium: The role of "suppressed" parathyroid function. Kidney Int 44:860-866, 1993
19. Brown EM, Wilson RE, Eastmen RC, Pallotta J, Marinick S: Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 54:172-179, 1982
20. Calliada F, Malberti F, Oldini C, Colecchia M, Soana G, Passamonti C: L'uso del color-doppler nell'esame delle paratiroidi iperplastiche: Correlazione tra velocità di flusso e attività ormonale nei pazienti con iperparatiroidismo, in Rovelli E, Samori G (eds): L'Iperparatiroidismo Primitivo e Secondario. Milano, Italy, Wichtig, 1992, pp 99-106
21. Collett D: Modelling Survival Data in Medical Research. London, UK, Chapman E. Hall, 1994
22. Fine A, Cox D, Fontaine B: Elevation of serum phosphate affects parathyroid hormone levels in only 50% of hemodialysis patients, which is unrelated to changes in serum calcium. J Am Soc Nephrol 3:1947-1953, 1993
23. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y: More severe form of parathyroid hyperplasia is associated with decreased calcitriol receptor density in chronic uremic patients. J Am Soc Nephrol 3:695-699, 1992
24. Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H: Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16:595-603, 1992
25. Brown ÉM, Gamba G, Riccardi D, Lombardi D, Butters R, Kifor O, Sun A, Hediger MA, Litton J, Hebert SC: Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 366:575-580, 1993
26. Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi ML: Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76:139-144, 1993
27. Malberti F, Corradi B, Pagliari B, Romanini D, Gazo A, Sidoti A, Baretta A, Bellazzi R, Imbasciati E: The sigmoidal parathyroid hormone-ionized calcium curve and the set point of calcium in hemodialysis and continuous ambulatory peritoneal dialysis. Perit Dial Int 13:S476-S479, 1993
28. Malberti F, Corradi B, Cosci P, Colecchia M, Leopardi O, Grossi L, Oldini C, Imbasciati E: Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism. Nephrol Dial Transplant 11:81-87, 1996
29. Goodman WG, Belin T, Gales B, Juppner H, Segre GV, Salusky IB: Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism. Kidney Int 48:1553-1558, 1995
30. Ouseph R, Leiser JD, Moe SM: Calcitriol and the parathyroid hormone-ionized calcium curve: A comparison of methodologic approaches. J Am Soc Nephrol 7:497-505, 1996
31. Felsenfeld AJ, Jara A, Pahl M, Bover J, Rodriguez M: Differences in the dynamics of parathyroid hormone secretion in hemodialysis patients with marked secondary hyperparathyroidism. J Am Soc Nephrol 6:1371-1378, 1995
32. Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Heath H: Calcium infusion suggests a "set point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76:715-720, 1993
33. Andress DL, Norris KC, Coburn JW, Slatopolsky E, Sherrard DJ: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279, 1989
34. Goodman W, Ramirez J, Belin T, Chon Y, Gales B, Segre GV, Salusky IB: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166, 1994
35. Fournier A, Moriniere PH, Marie A: Adynamic bone disease - Is it actually a disease? Nephrol Dial Transplant 10:454-457, 1995